Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer?

Abdul Wahid, Maryam; Hussain, Hassan Ul; Ghouri, Hafsa; Khan, Tarneem; Rehan, Syeda Tayyaba; Mumtaz, Hassan

Abdul Wahid, Maryam; Hussain, Hassan Ul; Ghouri, Hafsa; Khan, Tarneem; Rehan, Syeda Tayyaba; Mumtaz, Hassan.

Afiliación

Abdul Wahid M; Dow University of Health Sciences.
Hussain HU; Dow University of Health Sciences.
Ghouri H; Karachi Medical and Dental College, Karachi.
Khan T; Dow University of Health Sciences.
Rehan ST; Dow University of Health Sciences.
Mumtaz H; Maroof International Hospital. Public Health Scholar, Health Services Academy, Islamabad, Pakistan.

Int J Surg ; 109(10): 3230-3233, 2023 10 01.

Article en En | MEDLINE | ID: mdl-37352527

Asunto(s)

Neoplasias de la Mama; Neoplasias de la Mama Triple Negativas; Humanos; Femenino; Poli Adenosina Difosfato Ribosa/metabolismo; Factor A de Crecimiento Endotelial Vascular; Neoplasias de la Mama Triple Negativas/tratamiento farmacológico; Neoplasias de la Mama/tratamiento farmacológico; Poli(ADP-Ribosa) Polimerasas/metabolismo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Límite: Female / Humans Idioma: En Revista: Int J Surg Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google